8 European Nations Stop AstraZeneca COVID-19 Vaccine on Reports of “Serious” Blood Clots


The European Medicines Agency (EMA) has announced that eight European countries have suspended the use of AstraZeneca’s COVID-19 vaccine due to reports of “serious” blood clots. The countries include Austria, Denmark, Estonia, Lithuania, Luxembourg, Norway, Iceland and Latvia.

The EMA said it was investigating the reports and would provide an update as soon as possible. It added that there is currently no evidence that the vaccine causes blood clots and that its benefits still outweigh any potential risks.

AstraZeneca said it was aware of the reports and was working with health authorities to investigate them further. It added that it had not seen any evidence of increased risk of pulmonary embolism or deep vein thrombosis in clinical trials or in post-marketing data.

The news comes after several other countries including Germany, France and Italy also temporarily suspended the use of AstraZeneca’s vaccine over similar concerns. The World Health Organization (WHO) has urged countries not to suspend their use of the vaccine until more information is available.

It remains unclear how long these suspensions will last or what impact they will have on Europe’s vaccination efforts.

Yes, Iceland has suspended the use of the AstraZeneca vaccine due to reports of rare blood clots in some people who have received the vaccine. The Icelandic Medicines Agency said it was suspending the use of the vaccine as a precautionary measure until further notice.

The government has implemented a number of measures to contain the spread of the virus, including travel restrictions, mandatory quarantine for travelers, and social distancing. Additionally, the government has provided financial assistance to those affected by the pandemic and has launched a national vaccination campaign.

The EMA has stated that the benefits of the vaccine outweigh the risks, and that it is still safe to use. However, they have recommended that healthcare professionals should be aware of the potential risk of blood clots and take appropriate action if they occur. They also recommend that people who have received the vaccine should seek medical attention if they experience any symptoms such as shortness of breath, chest pain, leg swelling or persistent abdominal pain.

The European Medicines Agency (EMA) has recommended that countries pause the use of the AstraZeneca vaccine while they investigate these reports. The EMA is also recommending that people who have already received the AstraZeneca vaccine should continue to be monitored for any signs or symptoms of a blood clot.

He states that all vaccines have the potential to cause adverse effects, and this is why it is important to be aware of the risks associated with any vaccine before getting it. He also emphasizes the importance of discussing these risks with a healthcare provider before getting vaccinated.

The European Medicines Agency (EMA) said the vaccine had been found to be safe and effective in preventing COVID-19, with no specific safety concerns identified. The agency also noted that the vaccine was easy to transport and store, making it suitable for use in all EU countries.

The EMA’s recommendation will now be sent to the European Commission for a final decision on whether to grant marketing authorization for the vaccine across the bloc. If approved, it would become the fourth coronavirus vaccine available in Europe, alongside those from Pfizer/BioNTech, Moderna and AstraZeneca.


The Danish Health Authority has suspended the use of the AstraZeneca vaccine for two weeks due to reports of blood clots in some people who have received the shot. The suspension is a precautionary measure while authorities investigate whether there is a link between the vaccine and the reported cases. The decision was made after several European countries, including Germany, France, Italy, and Spain, also suspended their use of the AstraZeneca vaccine.

The Danish Health Authority said that it will continue to monitor the situation closely and will make an informed decision about when to resume using the AstraZeneca vaccine once more information is available. In the meantime, they are encouraging people to get vaccinated with other available vaccines such as Pfizer-BioNTech or Moderna.

The European Medicines Agency (EMA) has concluded that the benefits of the AstraZeneca vaccine in preventing COVID-19 outweigh the risks of side effects. The EMA has also stated that there is no evidence to suggest a link between the vaccine and blood clots. The agency has recommended that healthcare professionals should continue to vaccinate people with the AstraZeneca vaccine, as it is an important tool in helping to protect people from COVID-19.

This statement is correct. Denmark’s suspension of the AstraZeneca vaccine shows that the detection systems for potential safety issues are working, and that most of these safety events are likely to be linked to natural processes rather than the vaccine itself. This is an important reminder that it is essential to monitor the safety of all vaccines, even those that have been approved for use.

Adam Barker, a Shore analyst, believes that the safety signal detection systems are working properly and it is important to follow up on any safety signals using the correct protocols. He also noted that data from the vaccine’s phase three trials suggests that most safety signals will not be linked to the vaccine.

This statement suggests that it is difficult to accurately assess the impact of a therapy on shareholder value until all the data related to the therapy has been collected and analyzed. This is because there are many factors that can influence the outcome, such as the cost of the therapy, its effectiveness, and any potential side effects. Therefore, it is important to wait until all of this information is available before making any decisions about investing in a particular therapy.

The cause of death is yet to be determined. The Indian government has ordered an investigation into the incident and has asked the state health department to submit a report within seven days. The government has also asked the vaccine manufacturer to provide all necessary information related to the incident.

The Indian Council of Medical Research (ICMR) has said that it is too early to draw any conclusions about the safety of Covishield vaccine based on this single case. It has also stated that such incidents are rare and should not deter people from getting vaccinated against covid-19.

The ICMR has urged people to get vaccinated as soon as possible, emphasizing that vaccines are safe and effective in preventing serious illness and death due to covid-19.

This is a reminder that even though the vaccine is safe and effective, it can still cause side effects in some people. Minister Hunt experienced mild side effects, including fever and chills, which are common after receiving the vaccine. He was monitored in hospital overnight and has since been discharged. The Australian government continues to encourage everyone to get vaccinated when it is their turn.

This report has not been confirmed by other sources, and the Oxford-AstraZeneca vaccine has been approved for use in people over 65 in many countries. The World Health Organization (WHO) states that the vaccine is safe and effective for all age groups, including those over 65.

Sweden and France have also suspended the use of AstraZeneca for people under 65, while Germany has only suspended its use for those over 65.

The coronavirus outbreak has been a global health crisis, with cases reported in more than 200 countries and territories around the world. The World Health Organization (WHO) declared the outbreak a pandemic on March 11, 2020.

As of April 8, 2021, there have been over 132 million confirmed cases of COVID-19 worldwide, resulting in over 2.86 million deaths. The United States has had the most cases and deaths of any country, with over 31 million cases and over 562 thousand deaths.

Governments around the world have implemented various measures to contain the spread of the virus, including travel restrictions, lockdowns, social distancing guidelines, and stay-at-home orders. Vaccines are being rolled out in many countries as well.

It is important to stay informed about the latest developments related to COVID-19 so that you can take steps to protect yourself and your loved ones from infection. Be sure to follow your local public health authority for up-to-date information on prevention measures and other resources available in your area.

Thank you for your interest in supporting GreatGameIndia. You can support us by making a donation through our website or by becoming a patron on Patreon.

We also accept tips and submissions via email at [email protected]. You can join us on WhatsApp for more intel and updates by sending a message to +91-9015-178-178.

Your contribution, however small, helps us keep afloat and continue our independent and investigative research based journalism on the Deep State threats facing humanity.

Thank you for your support!